$ROG

ROGERS CORP (ROG): Results of Operations and Financial Condition

ROGERS CORP (ROG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026resultsannouncement.htm EX-99.1 Document Rogers Corporation Reports Second Quarter 2026 Results • Net sales of $216.8 million increased 6.9% year-over-year (YoY) • Gross margin of 32.5% increased 90 basis points YoY • Net income of $13.6 million, versus a $73.6 mi

Original reporting
Published Jul 28, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 8:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ROG
Bullish
high confidence
Mentioned
$ROG
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ROGBullishHigh
01

Why it matters

The filing’s combination of Q2 performance and quantified Q3 guidance (net sales, gross margin, adjusted EPS, adjusted EBITDA, and capex) is actionable for traders updating earnings models and near-term expectations.

02

Market read

Q2 beat/improvement on adjusted EPS and EBITDA margin expansion, plus a specific Q3 guidance range, can drive immediate estimate revisions and sentiment.

03

What to watch

The Q2 year-over-year comparison is influenced by large prior-year impairment and restructuring charges; traders should focus on adjusted metrics and margin trajectory rather than GAAP alone.

Relevance 7/10Novelty 9/10Timing: after-hours/filing today, ahead of the Q2 results conference call at 5:00 pm ET

Background

This is Rogers Corporation’s SEC Form 8-K reporting Q2 2026 results (Item 2.02) and providing Q3 2026 financial outlook.

Company-level read

Ticker impact

$ROGBullishHigh confidence
Context

Rogers reported Q2 2026 net sales of $216.8M (+6.9% YoY) and guided Q3 2026 net sales to $233-$243 with adjusted EPS $1.10-$1.30.

Expected impact

Likely positive bias for the next trading session and into Q3 estimate updates, assuming the market had not fully priced the guidance range.

Evidence & confidence

The filing includes concrete GAAP and non-GAAP results plus explicit Q3 2026 guidance for net sales, gross margin, adjusted EPS, and adjusted EBITDA, which are direct inputs to valuation and near-term expectations.

Market effects

Signals demand improvement in Rogers’ industrial and electronics end markets, potentially supporting sentiment for engineered materials suppliers.

No specific regional macro catalyst beyond general end-market demand and supply chain challenges.

Mentions global operations and currency effects, but no new geopolitical or regulatory shock is disclosed.

Counterpoint

Despite the strong Q2 improvement, the company still cites supply chain challenges, so guidance could be vulnerable to execution or input-cost swings.

Key entities

  • Rogers Corporation

    NYSE-listed engineered materials company reporting Q2 2026 results and issuing Q3 2026 guidance.

  • Ali El-Haj

    President and CEO quoted on revenue growth, adjusted EPS improvement, and outlook for continued year-over-year improvement.

Related articles

$ROGMedAI 8/10

Why is Rogers stock rallying today? By Investing.com

Rogers stock rose about 3.5% in pre-open after its Q2 2026 results beat expectations, with adjusted EPS of $0.92 on revenue of $216.8 million versus $0.79 and $210.9 million. The company guided Q3 EPS of $1.10–$1.30 and revenue of $233–$243 million. The move follows a prior selloff tied to supply chain headwinds and a plant fire.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.